Compounds > buthionine sulfoximine
Page last updated: 2024-08-22

buthionine sulfoximine and ER-Negative PR-Negative HER2-Negative Breast Cancer

buthionine sulfoximine has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Bian, XW; Cao, Y; Ding, S; Duan, G; Hu, Y; Li, C; Ma, Z; Tian, G; Yang, Y; Zeng, L; Zhang, X; Zhao, B; Zhou, J1
Drude, N; Miran, T; Morgenroth, A; Mottaghy, FM; Vogg, ATJ1
Berger, T; Cappello, P; Cescon, DW; Chu, MF; Duncan, G; Garcia-Valero, M; Gorrini, C; Hodgson, K; Jafari, SM; Mak, TW; McGaha, TL; Palomero, L; Pujana, MA; Roux, C; Shinde, R; Silvester, J; Wakeham, A1

Other Studies

3 other study(ies) available for buthionine sulfoximine and ER-Negative PR-Negative HER2-Negative Breast Cancer

ArticleYear
A MOF-Based Potent Ferroptosis Inducer for Enhanced Radiotherapy of Triple Negative Breast Cancer.
    ACS nano, 2023, 07-25, Volume: 17, Issue:14

    Topics: Anesthetics, Local; Buthionine Sulfoximine; Cell Line, Tumor; Ferroptosis; Fibrinolytic Agents; Glutathione; Humans; Triple Negative Breast Neoplasms; Tumor Microenvironment

2023
Modulation of glutathione promotes apoptosis in triple-negative breast cancer cells.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2018, Volume: 32, Issue:5

    Topics: Animals; Buthionine Sulfoximine; Cell Line, Tumor; Deoxyuridine; DNA Breaks, Double-Stranded; Female; Fluorodeoxyglucose F18; Glutathione; Humans; Mice; Mice, Nude; Promoter Regions, Genetic; Reactive Oxygen Species; Triple Negative Breast Neoplasms; Xenograft Model Antitumor Assays

2018
Reactive oxygen species modulate macrophage immunosuppressive phenotype through the up-regulation of PD-L1.
    Proceedings of the National Academy of Sciences of the United States of America, 2019, 03-05, Volume: 116, Issue:10

    Topics: Animals; B7-H1 Antigen; Breast Neoplasms; Buthionine Sulfoximine; Cell Line, Tumor; Chemokines; Drug Therapy; Female; Glutathione; Humans; Immunosuppressive Agents; Macrophages; Mice; Paclitaxel; Phenotype; Reactive Oxygen Species; RNA, Messenger; Triple Negative Breast Neoplasms; Tumor Microenvironment; Up-Regulation

2019